PDB Short entry for 3CTQ HEADER TRANSFERASE 14-APR-08 3CTQ TITLE STRUCTURE OF MAP KINASE P38 IN COMPLEX WITH A 1-O-TOLYL-1,2,3- TITLE 2 TRIAZOLE-4-CARBOXAMIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: MITOGEN-ACTIVATED PROTEIN KINASE 14; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: MITOGEN-ACTIVATED PROTEIN KINASE P38 ALPHA, MAP KINASE P38 COMPND 5 ALPHA, CYTOKINE SUPPRESSIVE ANTI-INFLAMMATORY DRUG-BINDING PROTEIN, COMPND 6 CSAID-BINDING PROTEIN, CSBP, MAX-INTERACTING PROTEIN 2, MAP KINASE COMPND 7 MXI2, SAPK2A; COMPND 8 EC: 2.7.11.24; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: MAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MAPK14, CSBP, CSBP1, CSBP2, CSPB1, MXI2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI KEYWDS TWO LOBE KINASE FOLD, N-TERMINAL BETA-SHEET, C-TERMINAL ALPHA-HELIX, KEYWDS 2 ALTERNATIVE SPLICING, ATP-BINDING, CYTOPLASM, KINASE, NUCLEOTIDE- KEYWDS 3 BINDING, NUCLEUS, PHOSPHOPROTEIN, POLYMORPHISM, SERINE/THREONINE- KEYWDS 4 PROTEIN KINASE, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR K.QIAN REVDAT 4 21-FEB-24 3CTQ 1 REMARK SEQADV REVDAT 3 24-FEB-09 3CTQ 1 VERSN REVDAT 2 17-JUN-08 3CTQ 1 JRNL REVDAT 1 27-MAY-08 3CTQ 0 JRNL AUTH D.A.COGAN,R.AUNGST,E.C.BREINLINGER,T.FADRA,D.R.GOLDBERG, JRNL AUTH 2 M.H.HAO,R.KROE,N.MOSS,C.PARGELLIS,K.C.QIAN,A.D.SWINAMER JRNL TITL STRUCTURE-BASED DESIGN AND SUBSEQUENT OPTIMIZATION OF JRNL TITL 2 2-TOLYL-(1,2,3-TRIAZOL-1-YL-4-CARBOXAMIDE) INHIBITORS OF P38 JRNL TITL 3 MAP KINASE. JRNL REF BIOORG.MED.CHEM.LETT. V. 18 3251 2008 JRNL REFN ISSN 0960-894X JRNL PMID 18462940 JRNL DOI 10.1016/J.BMCL.2008.04.043 REMARK 2 REMARK 2 RESOLUTION. 1.95 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.95 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 88.0 REMARK 3 NUMBER OF REFLECTIONS : 23633 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING SET) : 0.230 REMARK 3 FREE R VALUE : 0.269 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 8.700 REMARK 3 FREE R VALUE TEST SET COUNT : 2337 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2705 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 42 REMARK 3 SOLVENT ATOMS : 143 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 32.99 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.01300 REMARK 3 B22 (A**2) : 0.05500 REMARK 3 B33 (A**2) : -0.04200 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.492 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.420 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.102 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.953 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : DNA-RNA_REP.PARAM REMARK 3 PARAMETER FILE 3 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 4 : ION.PARAM REMARK 3 PARAMETER FILE 5 : BIRB2371.PAR REMARK 3 PARAMETER FILE 6 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 TOPOLOGY FILE 2 : NULL REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 TOPOLOGY FILE 6 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3CTQ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 24-APR-08. REMARK 100 THE DEPOSITION ID IS D_1000047198. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : NULL REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU300 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : NULL REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 24353 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.950 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 88.0 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.95 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 50.00 REMARK 200 COMPLETENESS FOR SHELL (%) : 88.0 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.39 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.25 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 32.72500 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 37.07000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 36.94500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 37.07000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 32.72500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 36.94500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LEU A 171 REMARK 465 ALA A 172 REMARK 465 ARG A 173 REMARK 465 HIS A 174 REMARK 465 THR A 175 REMARK 465 ASP A 176 REMARK 465 ASP A 177 REMARK 465 GLU A 178 REMARK 465 MET A 179 REMARK 465 THR A 180 REMARK 465 GLY A 181 REMARK 465 TYR A 182 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 14 -97.33 68.49 REMARK 500 SER A 56 -101.04 -45.94 REMARK 500 ARG A 57 66.50 -114.66 REMARK 500 PHE A 99 105.23 -59.01 REMARK 500 CYS A 119 -114.10 -75.89 REMARK 500 ARG A 149 -7.58 77.14 REMARK 500 ASP A 150 40.47 -144.89 REMARK 500 MET A 198 100.01 36.10 REMARK 500 HIS A 199 28.96 148.20 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 337 A 1 DBREF 3CTQ A 5 352 UNP Q16539 MK14_HUMAN 5 352 SEQADV 3CTQ ALA A 14 UNP Q16539 ASN 14 CONFLICT SEQADV 3CTQ HIS A 48 UNP Q16539 LEU 48 CONFLICT SEQADV 3CTQ ALA A 120 UNP Q16539 GLN 120 CONFLICT SEQADV 3CTQ ALA A 263 UNP Q16539 THR 263 CONFLICT SEQRES 1 A 348 ARG PRO THR PHE TYR ARG GLN GLU LEU ALA LYS THR ILE SEQRES 2 A 348 TRP GLU VAL PRO GLU ARG TYR GLN ASN LEU SER PRO VAL SEQRES 3 A 348 GLY SER GLY ALA TYR GLY SER VAL CYS ALA ALA PHE ASP SEQRES 4 A 348 THR LYS THR GLY HIS ARG VAL ALA VAL LYS LYS LEU SER SEQRES 5 A 348 ARG PRO PHE GLN SER ILE ILE HIS ALA LYS ARG THR TYR SEQRES 6 A 348 ARG GLU LEU ARG LEU LEU LYS HIS MET LYS HIS GLU ASN SEQRES 7 A 348 VAL ILE GLY LEU LEU ASP VAL PHE THR PRO ALA ARG SER SEQRES 8 A 348 LEU GLU GLU PHE ASN ASP VAL TYR LEU VAL THR HIS LEU SEQRES 9 A 348 MET GLY ALA ASP LEU ASN ASN ILE VAL LYS CYS ALA LYS SEQRES 10 A 348 LEU THR ASP ASP HIS VAL GLN PHE LEU ILE TYR GLN ILE SEQRES 11 A 348 LEU ARG GLY LEU LYS TYR ILE HIS SER ALA ASP ILE ILE SEQRES 12 A 348 HIS ARG ASP LEU LYS PRO SER ASN LEU ALA VAL ASN GLU SEQRES 13 A 348 ASP CYS GLU LEU LYS ILE LEU ASP PHE GLY LEU ALA ARG SEQRES 14 A 348 HIS THR ASP ASP GLU MET THR GLY TYR VAL ALA THR ARG SEQRES 15 A 348 TRP TYR ARG ALA PRO GLU ILE MET LEU ASN TRP MET HIS SEQRES 16 A 348 TYR ASN GLN THR VAL ASP ILE TRP SER VAL GLY CYS ILE SEQRES 17 A 348 MET ALA GLU LEU LEU THR GLY ARG THR LEU PHE PRO GLY SEQRES 18 A 348 THR ASP HIS ILE ASP GLN LEU LYS LEU ILE LEU ARG LEU SEQRES 19 A 348 VAL GLY THR PRO GLY ALA GLU LEU LEU LYS LYS ILE SER SEQRES 20 A 348 SER GLU SER ALA ARG ASN TYR ILE GLN SER LEU ALA GLN SEQRES 21 A 348 MET PRO LYS MET ASN PHE ALA ASN VAL PHE ILE GLY ALA SEQRES 22 A 348 ASN PRO LEU ALA VAL ASP LEU LEU GLU LYS MET LEU VAL SEQRES 23 A 348 LEU ASP SER ASP LYS ARG ILE THR ALA ALA GLN ALA LEU SEQRES 24 A 348 ALA HIS ALA TYR PHE ALA GLN TYR HIS ASP PRO ASP ASP SEQRES 25 A 348 GLU PRO VAL ALA ASP PRO TYR ASP GLN SER PHE GLU SER SEQRES 26 A 348 ARG ASP LEU LEU ILE ASP GLU TRP LYS SER LEU THR TYR SEQRES 27 A 348 ASP GLU VAL ILE SER PHE VAL PRO PRO PRO HET 337 A 1 42 HETNAM 337 N-BENZYL-1-[5-({5-TERT-BUTYL-2-METHOXY-3- HETNAM 2 337 [(METHYLSULFONYL)AMINO]PHENYL}CARBAMOYL)-2- HETNAM 3 337 METHYLPHENYL]-1H-1,2,3-TRIAZOLE-4-CARBOXAMIDE FORMUL 2 337 C30 H34 N6 O5 S FORMUL 3 HOH *143(H2 O) HELIX 1 1 GLY A 31 ALA A 34 5 4 HELIX 2 2 SER A 61 MET A 78 1 18 HELIX 3 3 LEU A 113 LYS A 118 1 6 HELIX 4 4 THR A 123 ALA A 144 1 22 HELIX 5 5 LYS A 152 SER A 154 5 3 HELIX 6 6 ALA A 184 ARG A 189 5 6 HELIX 7 7 ALA A 190 LEU A 195 1 6 HELIX 8 8 THR A 203 GLY A 219 1 17 HELIX 9 9 ASP A 227 GLY A 240 1 14 HELIX 10 10 GLY A 243 LYS A 248 1 6 HELIX 11 11 SER A 252 LEU A 262 1 11 HELIX 12 12 ASN A 269 PHE A 274 1 6 HELIX 13 13 ASN A 278 LEU A 289 1 12 HELIX 14 14 ASP A 292 ARG A 296 5 5 HELIX 15 15 THR A 298 HIS A 305 1 8 HELIX 16 16 ALA A 306 ALA A 309 5 4 HELIX 17 17 GLN A 325 ARG A 330 5 6 HELIX 18 18 LEU A 333 SER A 347 1 15 SHEET 1 A 2 PHE A 8 LEU A 13 0 SHEET 2 A 2 THR A 16 PRO A 21 -1 O TRP A 18 N GLN A 11 SHEET 1 B 5 TYR A 24 PRO A 29 0 SHEET 2 B 5 VAL A 38 ASP A 43 -1 O ALA A 40 N SER A 28 SHEET 3 B 5 ARG A 49 LYS A 54 -1 O VAL A 52 N CYS A 39 SHEET 4 B 5 TYR A 103 HIS A 107 -1 O THR A 106 N ALA A 51 SHEET 5 B 5 ASP A 88 PHE A 90 -1 N ASP A 88 O VAL A 105 SHEET 1 C 3 ALA A 111 ASP A 112 0 SHEET 2 C 3 LEU A 156 VAL A 158 -1 O VAL A 158 N ALA A 111 SHEET 3 C 3 LEU A 164 ILE A 166 -1 O LYS A 165 N ALA A 157 SITE 1 AC1 19 TYR A 35 ALA A 51 LYS A 53 ARG A 70 SITE 2 AC1 19 GLU A 71 LEU A 75 MET A 78 ILE A 84 SITE 3 AC1 19 THR A 106 HIS A 107 LEU A 108 MET A 109 SITE 4 AC1 19 GLY A 110 ALA A 111 ASP A 112 LEU A 167 SITE 5 AC1 19 ASP A 168 GLY A 170 HOH A 451 CRYST1 65.450 73.890 74.140 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015279 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013534 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013488 0.00000